372320 — Curocell Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Curocell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	41,143	40,979	7,126	39,917	9,581
Net Total Accounts Receivable
Net Total Receivables	22.1	616	2,183	746	168
Prepaid Expenses
Total Other Current Assets
Total Current Assets	41,446	64,161	41,397	42,787	13,047
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9,880	17,809	46,104	61,242	55,450
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	51,473	82,163	87,988	104,969	72,021
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45,922	84,837	106,648	3,270	38,751
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	49,050	94,399	135,586	45,870	42,567
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	2,424	-12,236	-47,598	59,100	29,454
Total Liabilities & Shareholders' Equity	51,473	82,163	87,988	104,969	72,021
Total Common Shares Outstanding